FREDUNPharmaceuticals
Fredun Pharmaceuticals Ltd — Cash Flow Statement
₹1671.80
-1.27%
Fredun Pharmaceuticals Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -35.17 Cr | -8.08 Cr | -23.90 Cr | -6.67 Cr | — |
| Capital Expenditure | -6.11 Cr | -7.64 Cr | -9.49 Cr | -4.29 Cr | — |
| End Cash Position | 5.22 Cr | 1.35 Cr | 3.44 Cr | 2.07 Cr | — |
| Beginning Cash Position | 1.52 Cr | 3.44 Cr | 2.07 Cr | 1.13 Cr | — |
| Changes In Cash | 3.70 Cr | -2.08 Cr | 1.36 Cr | 0.94 Cr | — |
| Financing Cash Flow | 39.12 Cr | 5.99 Cr | 25.18 Cr | 7.47 Cr | — |
| Net Other Financing Charges | -0.07 Cr | 0.68 Cr | 0.39 Cr | -0.99 Cr | — |
| Interest Paid Cff | -22.49 Cr | -13.65 Cr | -9.28 Cr | -4.67 Cr | — |
| Net Common Stock Issuance | 0.03 Cr | 0.00 | 0.00 | 0.00 | — |
| Net Issuance Payments Of Debt | 61.64 Cr | 18.96 Cr | 34.07 Cr | 13.13 Cr | — |
| Net Short Term Debt Issuance | 64.08 Cr | 21.61 Cr | 27.18 Cr | 0.20 Cr | — |
| Net Long Term Debt Issuance | -2.45 Cr | -2.64 Cr | 6.89 Cr | 12.93 Cr | — |
| Investing Cash Flow | -6.35 Cr | -7.64 Cr | -9.40 Cr | -4.14 Cr | — |
| Net Business Purchase And Sale | -0.36 Cr | — | — | — | — |
| Purchase Of Business | -0.36 Cr | — | — | — | — |
| Net PPE Purchase And Sale | -5.99 Cr | -7.64 Cr | -9.40 Cr | -4.14 Cr | — |
| Sale Of PPE | 0.11 Cr | 0.00 | 0.09 Cr | 0.14 Cr | — |
| Purchase Of PPE | -6.11 Cr | -7.64 Cr | -9.49 Cr | -4.29 Cr | — |
| Operating Cash Flow | -29.06 Cr | -0.44 Cr | -14.41 Cr | -2.38 Cr | — |
| Interest Received Cfo | 0.11 Cr | 0.01 Cr | 0.02 Cr | — | — |
| Change In Working Capital | -84.15 Cr | -42.26 Cr | -43.57 Cr | -18.77 Cr | — |
| Change In Other Current Liabilities | 13.02 Cr | 0.72 Cr | -6.99 Cr | -3.22 Cr | — |
| Change In Other Current Assets | 7.79 Cr | 0.87 Cr | -14.32 Cr | 5.01 Cr | — |
| Change In Payable | 81.84 Cr | 3.60 Cr | 10.73 Cr | -11.34 Cr | — |
| Change In Inventory | -64.89 Cr | -28.47 Cr | -103.66 Cr | 21.11 Cr | — |
| Change In Receivables | -112.50 Cr | -30.38 Cr | 55.65 Cr | -48.56 Cr | — |
| Other Non Cash Items | 22.44 Cr | 12.96 Cr | 8.87 Cr | 5.66 Cr | — |
| Deferred Tax | 7.46 Cr | 5.83 Cr | 6.70 Cr | 2.26 Cr | — |
| Depreciation And Amortization | 5.04 Cr | 3.80 Cr | 2.81 Cr | 2.16 Cr | — |
| Depreciation | 5.04 Cr | 3.80 Cr | 2.81 Cr | 2.16 Cr | — |
| Net Income From Continuing Operations | 20.03 Cr | 15.62 Cr | 10.76 Cr | 6.31 Cr | — |
| Other Cash Adjustment Outside Changein Cash | — | -1000.00 | -1000.00 | -1000.00 | 1000.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Fredun Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.